BE899278A - HIGH-RELEASE ANTIMYCOTIC AGENT OF ACTIVE SUBSTANCE IN THE FORM OF A CREAM. - Google Patents

HIGH-RELEASE ANTIMYCOTIC AGENT OF ACTIVE SUBSTANCE IN THE FORM OF A CREAM.

Info

Publication number
BE899278A
BE899278A BE0/212659A BE212653A BE899278A BE 899278 A BE899278 A BE 899278A BE 0/212659 A BE0/212659 A BE 0/212659A BE 212653 A BE212653 A BE 212653A BE 899278 A BE899278 A BE 899278A
Authority
BE
Belgium
Prior art keywords
active substance
cream
release
antimycotic agent
agent
Prior art date
Application number
BE0/212659A
Other languages
French (fr)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE899278A publication Critical patent/BE899278A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Des crèmes qui contiennent du Bifonazol comme substance active avec 10-60% d'un agent d'étendage et 20-80% d'un solvant, exercent une bonne activité antimycotique et peuvent etre utilisées comme médicaments.Creams which contain Bifonazol as active substance with 10-60% of a spreading agent and 20-80% of a solvent, have good antimycotic activity and can be used as medicines.

BE0/212659A 1983-03-30 1984-03-29 HIGH-RELEASE ANTIMYCOTIC AGENT OF ACTIVE SUBSTANCE IN THE FORM OF A CREAM. BE899278A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (en) 1983-03-30 1983-03-30 ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF CREAM

Publications (1)

Publication Number Publication Date
BE899278A true BE899278A (en) 1984-10-01

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212659A BE899278A (en) 1983-03-30 1984-03-29 HIGH-RELEASE ANTIMYCOTIC AGENT OF ACTIVE SUBSTANCE IN THE FORM OF A CREAM.

Country Status (19)

Country Link
JP (1) JPS59184106A (en)
KR (1) KR840008284A (en)
AU (1) AU564956B2 (en)
BE (1) BE899278A (en)
CA (1) CA1212327A (en)
CH (1) CH660126A5 (en)
CY (1) CY1358A (en)
DE (1) DE3311701A1 (en)
ES (3) ES8503947A1 (en)
FR (1) FR2543435B1 (en)
GB (1) GB2137091B (en)
GR (1) GR81485B (en)
IT (1) IT1173761B (en)
KE (1) KE3704A (en)
LU (1) LU85271A1 (en)
PH (1) PH20420A (en)
PT (1) PT78313B (en)
SE (1) SE8401748L (en)
ZA (1) ZA842337B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (en) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl- (1) -methanes and their salts, processes for their preparation and medicaments containing them
DE3045915A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS
DE3045914A1 (en) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS
DE3045913A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE
DE3106635A1 (en) * 1981-02-23 1982-09-09 Bayer Ag ANTIMYCOTIC AGENT WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF PEN

Also Published As

Publication number Publication date
ES539290A0 (en) 1985-11-16
GB2137091A (en) 1984-10-03
ES8601693A1 (en) 1985-11-16
CH660126A5 (en) 1987-03-31
DE3311701A1 (en) 1984-10-04
AU2623684A (en) 1984-10-04
IT8420303A0 (en) 1984-03-29
SE8401748D0 (en) 1984-03-29
FR2543435A1 (en) 1984-10-05
ES8601692A1 (en) 1985-11-16
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
FR2543435B1 (en) 1988-06-17
SE8401748L (en) 1984-10-01
CA1212327A (en) 1986-10-07
ES539289A0 (en) 1985-11-16
PH20420A (en) 1987-01-05
KE3704A (en) 1987-03-27
GB2137091B (en) 1986-10-01
CY1358A (en) 1987-08-07
ES530846A0 (en) 1985-04-16
LU85271A1 (en) 1984-11-14
AU564956B2 (en) 1987-09-03
PT78313A (en) 1984-04-01
GB8408067D0 (en) 1984-05-10
GR81485B (en) 1984-12-11
IT1173761B (en) 1987-06-24
JPS59184106A (en) 1984-10-19
ES8503947A1 (en) 1985-04-16
KR840008284A (en) 1984-12-14

Similar Documents

Publication Publication Date Title
MY100359A (en) External pharmaceutical composition.
JPS5312844A (en) Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents
PT74703A (en) Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine
DE19875032I2 (en) Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing the same
IT7928417A0 (en) PHARMACEUTICAL COMPOSITIONS WITH EXALTATION OF THE THERAPEUTIC ACTIVITY OF CORTISONICS.
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
EP0136914A3 (en) Shampoo compositions
NL7903400A (en) PROCESS FOR THE PREPARATION OF ALPHA, BETA-UNSATURATED N-SUBSTITUATED CARBONIC ACID AMIDES.
MY100900A (en) Substituted phenylsulfonyloxybenzimidazolecarbamates, processes for their preparation and their use as medicaments.
DE2966411D1 (en) Imidazolylvinylethers, their preparation and application as active agent in pharmaceutical and biocidal compositions
MA19882A1 (en) Derivatives of w-amino acids, their preparation and use as well as the compositions containing these acids.
IL48238A (en) N-(4-halobenzyl)-n-sec.alkyln'-phenylureas,their preparation and fungicidal compositions containing them
NO941097D0 (en) Skin regenerating cosmetic
BE899278A (en) HIGH-RELEASE ANTIMYCOTIC AGENT OF ACTIVE SUBSTANCE IN THE FORM OF A CREAM.
FR2453648A1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON A QUINAZOLINONE EXERCISING ANALGESIC ACTION AND A MYOTONOLYTIC AGENT
BE899277A (en) HIGH-RELEASE ANTIMYCOTICS WITH ACTIVE SUBSTANCE IN THE FORM OF A SOLUTION AND SPRAY.
IT8521528A0 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8PHENYL-10 ANTRONE-9 AS THE ACTIVE INGREDIENT, AND PROCEDURE FOR PREPARATION OF THE ACTIVE INGREDIENT.
IT8121960A0 (en) COMPOUNDS WITH SIMILAR GABA ACTIVITY, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THEY INCLUDE.
IT8222873A0 (en) STEROID COMPOUNDS WITH CHOLERETIC ACTIVITY, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
HK45984A (en) Compositions containing n-(2-amino-3,5-dibromobenzyl)-n-methyl-cyclohexylamine and/or its salts
IT8319401A0 (en) PEPTIDE AND HORMONAL AGENT CONTAINING THE SAME AS THE ACTIVE INGREDIENT.
JPS53133207A (en) Liquid shampoo composition
IT8421627A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING 24,25-DIHYDROXYCOLECALCIFEROL AS THE ACTIVE INGREDIENT.
IT8222339A0 (en) COMPOUNDS WITH CALCIUM-ANTAGONIST ACTIVITY, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BAYER A.G.

Effective date: 20040329